Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies

计划入组 14 人 · 首次发布于 2019 年 7 月 25 日

Effects of Dynamine Ingestion on Various Indices of Sustained Energy

计划入组 25 人 · 首次发布于 2023 年 9 月 21 日

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

计划入组 49 人 · 首次发布于 2019 年 5 月 6 日

Dynamin activator

Dynasore

C₁₈H₁₄N₂O₄

Dnacin B1

DYNAMIC PHARMACEUTICALS

India

Animated Dynamics, Inc

United States

Vascular Dynamics, Inc.

United States

Walden Biosciences Advances Kidney Disease Therapies with WAL0921 and WAL0623

Walden Biosciences Strengthens Board with Appointment of Rare Disease Expert Howard Mayer

Phosphatidylcholine Decline Emerges as a Malleable Driver of Mitochondrial Aging